SEC Company Response from PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — Jun 21, 2018
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: June 21, 2018 · CIK: 0001095981 · Accession: 0001564590-18-015950
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-224502
Letter
VIA EDGAR Division of Corporation Finance Securities and Exchange Commission Re: Cytori Therapeutics, Inc. Registration Statement on Form S-1 Filed April 27, 2018 File No. 333-224502
Dear Mr. Jones:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Cytori Therapeutics, Inc., respectfully requests that the effective date of the Registration Statement on Form S-1 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on June 22, 2018, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Cheston J. Larson, Esq. of Latham & Watkins LLP at (858) 523-5435. Thank you for your assistance and cooperation in this matter.
Very truly yours,
CYTORI THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
cytx-corresp.htm
Cytori Therapeutics, Inc.
3020 Callan Road
San Diego, CA 92121
June 21, 2018
VIA EDGAR
Tom Jones
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Cytori Therapeutics, Inc.
Registration Statement on Form S-1
Filed April 27, 2018
File No. 333-224502
Dear Mr. Jones:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Cytori Therapeutics, Inc., respectfully requests that the effective date of the Registration Statement on Form S-1 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on June 22, 2018, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Cheston J. Larson, Esq. of Latham & Watkins LLP at (858) 523-5435. Thank you for your assistance and cooperation in this matter.
Very truly yours,
CYTORI THERAPEUTICS, INC.
By: /s/ Tiago M. Girão
Tiago M. Girão
Chief Financial Officer
cc:
Cheston J. Larson, Esq., Latham & Watkins LLP
Christopher G. Geissinger, Esq., Latham & Watkins LLP